209 related articles for article (PubMed ID: 23663560)
21. Quantitative measures of estrogen receptor expression in relation to breast cancer-specific mortality risk among white women and black women.
Ma H; Lu Y; Marchbanks PA; Folger SG; Strom BL; McDonald JA; Simon MS; Weiss LK; Malone KE; Burkman RT; Sullivan-Halley J; Deapen DM; Press MF; Bernstein L
Breast Cancer Res; 2013; 15(5):R90. PubMed ID: 24070170
[TBL] [Abstract][Full Text] [Related]
22. Geographic differences in the distribution of molecular subtypes of breast cancer in Brazil.
Carvalho FM; Bacchi LM; Pincerato KM; Van de Rijn M; Bacchi CE
BMC Womens Health; 2014 Aug; 14():102. PubMed ID: 25174527
[TBL] [Abstract][Full Text] [Related]
23. Racial comparison of receptor-defined breast cancer in Southern African women: subtype prevalence and age-incidence analysis of nationwide cancer registry data.
Dickens C; Duarte R; Zietsman A; Cubasch H; Kellett P; Schüz J; Kielkowski D; McCormack V
Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2311-21. PubMed ID: 25143359
[TBL] [Abstract][Full Text] [Related]
24. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status.
Howlader N; Altekruse SF; Li CI; Chen VW; Clarke CA; Ries LA; Cronin KA
J Natl Cancer Inst; 2014 Apr; 106(5):. PubMed ID: 24777111
[TBL] [Abstract][Full Text] [Related]
25. Functional analysis of single-nucleotide polymorphisms in the regulation of coactivator-associated arginine methyltransferase 1 expression and plasma homocysteine levels.
Liu X; Hao Y; Wang L; Li H; Lu X; Cao J; Hu Y; Mo X; Peng X; Gu D
Circ Cardiovasc Genet; 2014 Oct; 7(5):642-9. PubMed ID: 25064859
[TBL] [Abstract][Full Text] [Related]
26. Breast cancer in Ethiopia: evidence for geographic difference in the distribution of molecular subtypes in Africa.
Hadgu E; Seifu D; Tigneh W; Bokretsion Y; Bekele A; Abebe M; Sollie T; Merajver SD; Karlsson C; Karlsson MG
BMC Womens Health; 2018 Feb; 18(1):40. PubMed ID: 29444670
[TBL] [Abstract][Full Text] [Related]
27. CARM1 methylates chromatin remodeling factor BAF155 to enhance tumor progression and metastasis.
Wang L; Zhao Z; Meyer MB; Saha S; Yu M; Guo A; Wisinski KB; Huang W; Cai W; Pike JW; Yuan M; Ahlquist P; Xu W
Cancer Cell; 2014 Jan; 25(1):21-36. PubMed ID: 24434208
[TBL] [Abstract][Full Text] [Related]
28. Protein arginine methyltransferase CARM1 in human breast cancer.
Bacabac M; Liu P; Xu W
Endocrinology; 2024 Jun; ():. PubMed ID: 38878278
[TBL] [Abstract][Full Text] [Related]
29. Frequency of breast cancer subtypes among African American women in the AMBER consortium.
Allott EH; Geradts J; Cohen SM; Khoury T; Zirpoli GR; Bshara W; Davis W; Omilian A; Nair P; Ondracek RP; Cheng TD; Miller CR; Hwang H; Thorne LB; O'Connor S; Bethea TN; Bell ME; Hu Z; Li Y; Kirk EL; Sun X; Ruiz-Narvaez EA; Perou CM; Palmer JR; Olshan AF; Ambrosone CB; Troester MA
Breast Cancer Res; 2018 Feb; 20(1):12. PubMed ID: 29409530
[TBL] [Abstract][Full Text] [Related]
30. Protein arginine methyltransferase CARM1 attenuates the paraspeckle-mediated nuclear retention of mRNAs containing IRAlus.
Hu SB; Xiang JF; Li X; Xu Y; Xue W; Huang M; Wong CC; Sagum CA; Bedford MT; Yang L; Cheng D; Chen LL
Genes Dev; 2015 Mar; 29(6):630-45. PubMed ID: 25792598
[TBL] [Abstract][Full Text] [Related]
31. Cytoplasmic localization of alteration/deficiency in activation 3 (ADA3) predicts poor clinical outcome in breast cancer patients.
Mirza S; Rakha EA; Alshareeda A; Mohibi S; Zhao X; Katafiasz BJ; Wang J; Gurumurthy CB; Bele A; Ellis IO; Green AR; Band H; Band V
Breast Cancer Res Treat; 2013 Feb; 137(3):721-31. PubMed ID: 23288344
[TBL] [Abstract][Full Text] [Related]
32. Association of poor prognosis subtypes of breast cancer with estrogen receptor alpha methylation in Iranian women.
Izadi P; Mehrdad N; Foruzandeh F; Reza NM
Asian Pac J Cancer Prev; 2012; 13(8):4113-7. PubMed ID: 23098526
[TBL] [Abstract][Full Text] [Related]
33. Differential CARM1 expression in prostate and colorectal cancers.
Kim YR; Lee BK; Park RY; Nguyen NT; Bae JA; Kwon DD; Jung C
BMC Cancer; 2010 May; 10():197. PubMed ID: 20462455
[TBL] [Abstract][Full Text] [Related]
34. Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups.
Kurian AW; Fish K; Shema SJ; Clarke CA
Breast Cancer Res; 2010; 12(6):R99. PubMed ID: 21092082
[TBL] [Abstract][Full Text] [Related]
35. AMPK-SKP2-CARM1 signalling cascade in transcriptional regulation of autophagy.
Shin HJ; Kim H; Oh S; Lee JG; Kee M; Ko HJ; Kweon MN; Won KJ; Baek SH
Nature; 2016 Jun; 534(7608):553-7. PubMed ID: 27309807
[TBL] [Abstract][Full Text] [Related]
36. Specific protein methylation defects and gene expression perturbations in coactivator-associated arginine methyltransferase 1-deficient mice.
Yadav N; Lee J; Kim J; Shen J; Hu MC; Aldaz CM; Bedford MT
Proc Natl Acad Sci U S A; 2003 May; 100(11):6464-8. PubMed ID: 12756295
[TBL] [Abstract][Full Text] [Related]
37. Coactivator-associated arginine methyltransferase 1 (CARM1) is a positive regulator of the Cyclin E1 gene.
El Messaoudi S; Fabbrizio E; Rodriguez C; Chuchana P; Fauquier L; Cheng D; Theillet C; Vandel L; Bedford MT; Sardet C
Proc Natl Acad Sci U S A; 2006 Sep; 103(36):13351-6. PubMed ID: 16938873
[TBL] [Abstract][Full Text] [Related]
38. CARM1/PRMT4: Making Its Mark beyond Its Function as a Transcriptional Coactivator.
Suresh S; Huard S; Dubois T
Trends Cell Biol; 2021 May; 31(5):402-417. PubMed ID: 33485722
[TBL] [Abstract][Full Text] [Related]
39. Global mapping of CARM1 substrates defines enzyme specificity and substrate recognition.
Shishkova E; Zeng H; Liu F; Kwiecien NW; Hebert AS; Coon JJ; Xu W
Nat Commun; 2017 May; 8():15571. PubMed ID: 28537268
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women.
Ferguson NL; Bell J; Heidel R; Lee S; Vanmeter S; Duncan L; Munsey B; Panella T; Orucevic A
Breast J; 2013; 19(1):22-30. PubMed ID: 23240985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
